Work

Rationale and study design of ARCHER: a randomized, double-blind, Phase III study of dacomitinib versus erlotinib for advanced non-small-cell lung cancer

Year: 2012

Type: article

Study design: Study Protocol

Source: Clinical Investigation

DOI: 10.4155/cli.12.137

Authors: Michael Boyer, Pasi Antero Jänne, Tony Mok, Kenneth O’Byrne, Luis Paz-Ares, Suresh S Ramalingam, Jane Liang, Ian Taylor, Alicyn Campbell, Joseph O’Connell, Stephen Letrent, Vladan Antic

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2072096616

FWCI: 0.238

Cites: 22

Cited by: 2

Related to: 10